FREE Account Opening + No Clearing Fees

Vera Synthetics NSE SME IPO review (Avoid)

Review By Dilip Davda on March 21, 2018

Vera Synthetics Ltd. (VSL) is engaged in manufacturing of Fishing Nets, PP Yarns, PP/HDPE Ropes, PP Twines and Niwar. Company manufactures and market its products under our flagship brand “Sujlon” and are primarily used in fishing sector and other allied use thereon.Its manufacturing facility is divided into two units namely Division I and Division II (both situated in the same premises at Mamsa, Gujarat).

At present VSL caters majorly to domestic markets with its dealers, traders and distributors spread across different regions of the Country thus giving the advantage of widespread geographical presence. Currently it sells products either directly to traders/fishermen or through distribution network in Gujarat, Maharashtra, Kerala, Karnataka, Andhra Pradesh, Punjab, Tamil Nadu, Haryana, Uttar Pradesh, Delhi, Rajasthan, etc. It has recently ventured into export markets.

To part finance its working capital and general corpus fund needs, VSL is coming out with a maiden IPO of 1335000 equity shares of Rs. 10 each with a fixed price of Rs. 40 per share to mobilize Rs. 5.34 crore. Issue opens for subscription on 28.03.18 and will close on 04.04.18. Minimum application is to be made for 3000 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on NSE SME Emerge. Issue is solely lead managed by Pantomath Capital Advisors Pvt. Ltd. and Link Intime India Pvt. Ltd. is the registrar to the issue. Issue constitutes 27.05% of the post issue paid up capital of the company. It has issued entire equity at par and has also issued bonus shares in the ratio of 1 for 1 in October 2017. Average cost of acquisition of shares by the promoters is Rs. 0.44 and Rs. 2.19 per share. Post issue, its current paid up equity capital of Rs. 3.60 cr. will stand enhanced to Rs. 4.94 cr.

On performance front, VSL has posted turnover/net profits of Rs. 19.76 cr. / Rs. 0.33 cr. (FY14), Rs. 24.49 cr. / Rs. 0.05 cr. (FY15), Rs. 21.95 cr. / Rs. 0.27 cr. (FY16) and Rs.18.44 cr. / Rs.0.34 cr. (FY17). For first half of the current fiscal, it has incurred loss of Rs.-(1.03) cr. on a turnover of Rs. 9.72 cr. Thus while it has inconsistency in performance with declining trends in top line, it has posted huge loss for first half of the current fiscal, which might wipe out last five years earnings.   For last three fiscals, it has posted an average EPS of Rs.0.75 and an average RoNW of 5.81%. For first half, it has posted a negative EPS of Rs.-(2.86) and negative RoNW – (27.25%). Issue is priced at a P/BV of 3.81 on the basis of NAV of Rs.10.51 as on 30.09.17 and at a P/BV of 2.16 on the basis of its post issue NAV of Rs. 18.49. Due to negative earnings, P/E will be negative. It has shown Garware Wall as its listed peer that is trading at a P/E of around 21 (on BSE as on 21.03.18 closing).

On merchant banker’s front, this is 66th mandate from its stable in last three fiscals. Out of last 10 listings, 1 opened at discount to offer price, 1 just Rs. 0.05 paise up on offer price, 7 with a premium ranging from 4% to 20% and 1 (main board issue) with a premium of 130% on the offer price on the day of listing.

Conclusion / Investment Strategy

Company has inconsistent performance and has made loss for first half of current fiscal. Issue pricing is exorbitant. There is no harm in giving this issue a miss.

Reviewer recommends Avoid to the issue.

Review By Dilip Davda on March 21, 2018

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.

About Dilip Davda

Dilip Davda

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: ).

Vera Synthetic IPO FAQs

  1. 1. Why Vera Synthetic IPO?

    The initial public offer (IPO) of Vera Synthetic Limited offers an early investment opportunity in Vera Synthetic Limited. A stock market investor can buy Vera Synthetic IPO shares by applying in IPO before Vera Synthetic Limited shares get listed at the stock exchanges. An investor could invest in Vera Synthetic IPO for short term listing gain or a long term.

  2. 2. How is Vera Synthetic IPO?

    Read the Vera Synthetic IPO recommendations by the leading analyst and leading stock brokers.

  3. 3. Vera Synthetic IPO what should investors do?

    Vera Synthetic IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Vera Synthetic IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts in the above answer.

  4. 4. Is Vera Synthetic IPO good?

    Our recommendation for Vera Synthetic IPO is to avoid.

  5. 5. Is Vera Synthetic IPO worth Investing?

    As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to avoid the Vera Synthetic IPO.

  6. 6. When will Vera Synthetic IPO allotment status?

    The Vera Synthetic IPO allotment status will be available on or around [.]. The allotted shares will be credited in demat account by [.]. Visit Vera Synthetic IPO allotment status to check.

  7. 7. When will Vera Synthetic IPO list?

    The Vera Synthetic IPO will list on Thursday, April 12, 2018, at NSE SME.